Case report highlights minocycline sclerotherapy for canine LMs
Bottom line
A new Frontiers in Veterinary Science case report describes long-term local control of recurrent lymphatic malformations in a young mixed-breed dog using repeated minocycline sclerotherapy after surgery failed to prevent regrowth. The dog, a 3.5-year-old Chihuahua–Miniature Dachshund mix, had peripenile and inguinal cystic lesions that recurred after prior excision and continued to enlarge despite about three years of prednisolone therapy. After referral, clinicians performed surgical debulking, confirmed lymphatic malformation on histopathology, and then treated recurrent postoperative cysts with ultrasound-guided intralesional minocycline, limiting the dose to 10 mg/kg per session. The report says the approach achieved resolution or suppression of major cystic lesions with preserved function through 535 days of follow-up. (frontiersin.org)
Why it matters: For veterinary professionals, the case adds a practical data point in a condition with very limited canine treatment literature and a high risk of recurrence after incomplete excision. The authors note that veterinary reports are rare, and that only one prior veterinary publication had described sclerotherapy for lymphatic malformations, but in combination with surgery, electrochemotherapy, and radiation, making the independent effect hard to judge. In human medicine, sclerotherapy is already a standard option for lymphatic malformations, especially when lesions are recurrent or difficult to fully resect, so this report may help clinicians think about image-guided sclerosant therapy as an adjunct when surgery alone is unlikely to provide durable control. (frontiersin.org)
What to watch: Whether additional canine case series can clarify dosing, safety, lesion selection, and how minocycline compares with other sclerosants used more commonly in human lymphatic malformation care. (frontiersin.org)
Key facts
- Study type
- Case report
- Species
- Dog
- Age
- 3.5-year-old
- Breed
- Chihuahua–Miniature Dachshund mix
- Condition
- Recurrent lymphatic malformations
- Lesion location
- Peripenile and inguinal
- Treatment
- Repeated ultrasound-guided intralesional minocycline sclerotherapy after surgery
- Dose limit
- 10 mg/kg per session
- Follow-up
- 535 days
A newly published case report in Frontiers in Veterinary Science suggests minocycline sclerotherapy may offer a useful salvage option for recurrent canine lymphatic malformations after surgery. In the reported case, a 3-year-6-month-old mixed-breed dog achieved long-term local disease control after repeated intralesional minocycline treatments were added following surgical resection, with good clinical function maintained 535 days postoperatively. (frontiersin.org)
That matters because lymphatic malformations remain uncommon and poorly characterized in veterinary medicine, where terminology has varied and treatment experience is thin. The Frontiers authors say most previously reported canine cases were managed surgically, even though complete excision can be difficult when lesion margins are poorly defined. They also note that, to their knowledge, only one prior veterinary report described sclerotherapy for this disease, and that case used a multimodal combination of surgery, electrochemotherapy, sclerotherapy, and radiation therapy rather than isolating the effect of the sclerosant itself. (frontiersin.org)
In this dog, the clinical course illustrated the management challenge. The patient had vesicular lesions on the left side of the penis from a young age, had already undergone extensive surgery elsewhere, and experienced local recurrence shortly afterward. Prednisolone at 0.5 to 2.0 mg/kg/day was continued for about three years, but the lesions gradually enlarged and eventually caused gait disturbance and reduced activity before referral. At the referral hospital, clinicians documented a soft, multilobulated left inguinal mass measuring about 100 × 60 × 40 mm, with ultrasonography showing multiple cystic structures and no internal blood flow on Doppler interrogation. (frontiersin.org)
After resection, recurrence was detected again just 14 days later, with multiple cystic lesions in the left cranial abdomen and around the penis. The team then performed ultrasound-guided sclerotherapy using minocycline at 15 mg/mL mixed with 2% lidocaine to reduce pain, aspirating cyst fluid and instilling enough solution to fill each cavity. One to three lesions were treated per session, with a total dose capped at 10 mg/kg each time. The authors report that this strategy prevented marked enlargement of cystic lesions during long-term follow-up, while large cysts either resolved or remained suppressed. They describe only mild transient discomfort, including occasional vocalization immediately after injection and short-lived decreased activity. (frontiersin.org)
The broader context comes largely from human medicine, where sclerotherapy is already a standard management option for lymphatic malformations alongside surgery. Reviews of human practice describe percutaneous sclerotherapy as a minimally invasive, image-guided approach that can be repeated, particularly for macrocystic disease or postoperative recurrence. Commonly used agents in people include doxycycline, bleomycin, OK-432, ethanol, and sodium tetradecyl sulfate. The veterinary authors argue that minocycline may work through endothelial injury related to its acidity and cytotoxicity, promoting fibrosis of the cyst wall and reducing fluid reaccumulation. (frontiersin.org)
There does not appear to be much published outside commentary on this specific report yet, which isn't unusual for a single case report published today, September 17, 2026. Still, the paper’s significance is easy to place within the existing literature: it offers a cleaner signal than the 2021 canine abdominal lymphatic malformation report because the current case more directly links repeated sclerotherapy with durable local control after recurrence. That’s an inference based on comparing the two reports, not a head-to-head study result. (frontiersin.org)
Why it matters: For clinicians, the takeaway isn’t that minocycline sclerotherapy is ready to become standard of care, but that it may be a reasonable adjunct when resection is incomplete, recurrence is rapid, or anatomy makes aggressive surgery undesirable. The case also highlights a familiar problem in rare disorders: long-term corticosteroid therapy did not stop progression and likely contributed to adverse effects such as skin thinning, alopecia, and coat changes. A minimally invasive, ultrasound-guided option that can be repeated in selected cysts could be especially relevant for referral surgery, oncology, and interventional teams managing function-limiting lesions in difficult locations. (frontiersin.org)
What to watch: The next step is more evidence, ideally small case series that define which lesion types respond best, how many sessions are typically needed, what adverse effects emerge with repeated dosing, and whether minocycline offers advantages over other sclerosants borrowed from human medicine. Until then, this report is best read as an early proof of concept for a rare but frustrating canine condition. (frontiersin.org)